| Oric Pharmaceuticals, Inc. | ORIC | Richard A. HeymanDirDERIV | Oct 1 | MPLAN | 3,500 | $0.00 | —? |
| Oric Pharmaceuticals, Inc. | ORIC | Richard A. HeymanDir | Oct 1 | SPLAN | 3,200 | $12.91 | $41K |
| Oric Pharmaceuticals, Inc. | ORIC | Richard A. HeymanDir | Oct 1 | SPLAN | 3,500 | $12.91 | $45K |
| Oric Pharmaceuticals, Inc. | ORIC | Richard A. HeymanDir | Oct 1 | MPLAN | 3,500 | $1.60 | $6K |
| Oric Pharmaceuticals, Inc. | ORIC | Richard A. HeymanDirDERIV | Jul 24 | MPLAN | 3,500 | $0.00 | —? |
| Oric Pharmaceuticals, Inc. | ORIC | Richard A. HeymanDir | Jul 24 | SPLAN | 6,100 | $12.02 | $73K |
| Oric Pharmaceuticals, Inc. | ORIC | Richard A. HeymanDir | Jul 24 | SPLAN | 7,000 | $12.02 | $84K |
| Oric Pharmaceuticals, Inc. | ORIC | Richard A. HeymanDir | Jul 24 | MPLAN | 3,500 | $1.60 | $6K |
| Oric Pharmaceuticals, Inc. | ORIC | Richard A. HeymanDir | Jul 6 | SPLAN | 300 | $12.00 | $4K |
| Enliven Therapeutics, Inc. | ELVN | Richard A. HeymanDir | Feb 17 | SPLAN | 1,230 | $26.18 | $32K |
| Enliven Therapeutics, Inc. | ELVN | Richard A. HeymanDirDERIV | Feb 12 | A | 19,234 | $0.00 | —? |
| Enliven Therapeutics, Inc. | ELVN | Richard A. HeymanDir | Jan 20 | SPLAN | 718 | $26.96 | $19K |
| Enliven Therapeutics, Inc. | ELVN | Richard A. HeymanDir | Jan 20 | SPLAN | 512 | $26.46 | $14K |
| Oric Pharmaceuticals, Inc. | ORIC | Richard A. HeymanDir | Jan 16 | SPLAN | 3,200 | $12.00 | $38K |
| Oric Pharmaceuticals, Inc. | ORIC | Richard A. HeymanDir | Jan 16 | SPLAN | 3,500 | $12.00 | $42K |
| Enliven Therapeutics, Inc. | ELVN | Richard A. HeymanDir | Jan 9 | SPLAN | 4,285 | $25.00 | $107K |
| Enliven Therapeutics, Inc. | ELVN | Richard A. HeymanDir | Jan 8 | SPLAN | 8,015 | $25.04 | $201K |
| Enliven Therapeutics, Inc. | ELVN | Richard A. HeymanDir | Jan 8 | SPLAN | 1,620 | $25.00 | $41K |
| Oric Pharmaceuticals, Inc. | ORIC | Richard A. HeymanDirDERIV | Jan 2 | A | 40,000 | $0.00 | —? |